Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

 739.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,717.00
  • 52 Week Low: 576.50
  • Currency: UK Pounds
  • Shares Issued: 124.76m
  • Volume: 0
  • Market Cap: £921.97m
  • RiskGrade: 314
  • Beta: 0.04

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

1 Day Chart (01-04-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1.9% 22.9%
ROCE n/a  
Latest F'cast
P/E n/a 6.2
PEG n/a n/a
Pr/Revenue 1.0 0.9
Pr/Book n/a  
Latest F'cast
Revenue 8.7% -31.8%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Indivior Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 647.00 (173.00) 40.00¢ 17.6 n/a -67% n/a 0.0%
31-Dec-21 791.00 190.00 19.20¢ 86.4 n/a -52% n/a 0.0%
31-Dec-22 901.00 (95.00) (38.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1,093.00 1.00 1.00¢ 1,530.2 n/a n/a n/a 0.0%
31-Dec-24 1,188.00 (43.00) (36.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Indivior Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,046.32 239.33 100.29p 7.4 n/a n/a n/a 0.0%
31-Dec-26 1,090.86 264.30 116.65p 6.3 0.4 +16% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Indivior Company Announcements

Total Voting Rights 01-Apr-2025 11:19 RNS
Holding(s) in Company 28-Mar-2025 08:33 RNS
Notice of AGM 27-Mar-2025 14:00 RNS

Indivior ShareCast News

Indivior shrinks board following pressure from a... 04-Mar-2025 ShareCast
London close: Stocks mixed on corporate earnings... 27-Feb-2025 ShareCast
Pharma veteran Ciaffoni to take CEO reins at Ind... 27-Feb-2025 ShareCast

Latest Indivior Director Deals

Traded Action Notifier PriceAmountValue
17-Mar-25 Transfer From Mark Crossley 0.000p 9,974 £0.00
10-Mar-25 Transfer From Mark Crossley 0.000p 243,282 £0.00
10-Mar-25 Buy Keith Humphreys 710.34p 1,500 £10,655.14

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Indivior Market Data

Currency UK Pounds
Share Price 739.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,717.00
52 Week Low 576.50
Volume 0
Shares Issued 124.76m
Market Cap £921.97m
Beta 0.04
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.53% below the market average54.53% below the market average54.53% below the market average54.53% below the market average54.53% below the market average
54.17% above the sector average54.17% above the sector average54.17% above the sector average54.17% above the sector average54.17% above the sector average
Price Trend
68.75% above the market average68.75% above the market average68.75% above the market average68.75% above the market average68.75% above the market average
10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average
Income Not Available
Growth
52.40% above the market average52.40% above the market average52.40% above the market average52.40% above the market average52.40% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page